nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.137	0.21	CiPCiCtD
Ganciclovir—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.137	0.21	CiPCiCtD
Ganciclovir—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.137	0.21	CiPCiCtD
Ganciclovir—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.137	0.21	CiPCiCtD
Ganciclovir—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.104	0.159	CiPCiCtD
Ganciclovir—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.04	0.157	CbGbCtD
Ganciclovir—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0374	0.147	CbGbCtD
Ganciclovir—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0303	0.119	CbGbCtD
Ganciclovir—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0275	0.108	CbGbCtD
Ganciclovir—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0267	0.105	CbGbCtD
Ganciclovir—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0241	0.0947	CbGbCtD
Ganciclovir—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0229	0.0896	CbGbCtD
Ganciclovir—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0179	0.0702	CbGbCtD
Ganciclovir—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0159	0.0624	CbGbCtD
Ganciclovir—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0123	0.0483	CbGbCtD
Ganciclovir—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.8e-05	0.000414	CcSEcCtD
Ganciclovir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.000414	CcSEcCtD
Ganciclovir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.79e-05	0.000414	CcSEcCtD
Ganciclovir—Chest pain—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.000413	CcSEcCtD
Ganciclovir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.000413	CcSEcCtD
Ganciclovir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.000413	CcSEcCtD
Ganciclovir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.78e-05	0.000412	CcSEcCtD
Ganciclovir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.78e-05	0.000412	CcSEcCtD
Ganciclovir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.78e-05	0.000412	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.76e-05	0.00041	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.75e-05	0.000409	CcSEcCtD
Ganciclovir—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.75e-05	0.000409	CcSEcCtD
Ganciclovir—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.75e-05	0.000409	CcSEcCtD
Ganciclovir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.75e-05	0.000408	CcSEcCtD
Ganciclovir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000408	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.74e-05	0.000408	CcSEcCtD
Ganciclovir—Cough—Saquinavir—acquired immunodeficiency syndrome	3.74e-05	0.000408	CcSEcCtD
Ganciclovir—Pain—Indinavir—acquired immunodeficiency syndrome	3.72e-05	0.000405	CcSEcCtD
Ganciclovir—Constipation—Indinavir—acquired immunodeficiency syndrome	3.72e-05	0.000405	CcSEcCtD
Ganciclovir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.71e-05	0.000405	CcSEcCtD
Ganciclovir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.71e-05	0.000405	CcSEcCtD
Ganciclovir—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.71e-05	0.000405	CcSEcCtD
Ganciclovir—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.000404	CcSEcCtD
Ganciclovir—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.7e-05	0.000403	CcSEcCtD
Ganciclovir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.69e-05	0.000403	CcSEcCtD
Ganciclovir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.69e-05	0.000403	CcSEcCtD
Ganciclovir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.69e-05	0.000402	CcSEcCtD
Ganciclovir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.69e-05	0.000402	CcSEcCtD
Ganciclovir—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000402	CcSEcCtD
Ganciclovir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.68e-05	0.000401	CcSEcCtD
Ganciclovir—Nausea—Didanosine—acquired immunodeficiency syndrome	3.68e-05	0.000401	CcSEcCtD
Ganciclovir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.67e-05	0.000401	CcSEcCtD
Ganciclovir—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.67e-05	0.0004	CcSEcCtD
Ganciclovir—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.0004	CcSEcCtD
Ganciclovir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.66e-05	0.000399	CcSEcCtD
Ganciclovir—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.66e-05	0.000399	CcSEcCtD
Ganciclovir—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.65e-05	0.000398	CcSEcCtD
Ganciclovir—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000398	CcSEcCtD
Ganciclovir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000398	CcSEcCtD
Ganciclovir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000398	CcSEcCtD
Ganciclovir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.64e-05	0.000396	CcSEcCtD
Ganciclovir—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.63e-05	0.000396	CcSEcCtD
Ganciclovir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.62e-05	0.000395	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.000395	CcSEcCtD
Ganciclovir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.61e-05	0.000394	CcSEcCtD
Ganciclovir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000393	CcSEcCtD
Ganciclovir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.58e-05	0.000391	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.58e-05	0.00039	CcSEcCtD
Ganciclovir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.57e-05	0.000389	CcSEcCtD
Ganciclovir—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.000389	CcSEcCtD
Ganciclovir—Cough—Lamivudine—acquired immunodeficiency syndrome	3.57e-05	0.000389	CcSEcCtD
Ganciclovir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.57e-05	0.000389	CcSEcCtD
Ganciclovir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.56e-05	0.000388	CcSEcCtD
Ganciclovir—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.56e-05	0.000388	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.55e-05	0.000388	CcSEcCtD
Ganciclovir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.55e-05	0.000388	CcSEcCtD
Ganciclovir—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	3.55e-05	0.000387	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.55e-05	0.000387	CcSEcCtD
Ganciclovir—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.54e-05	0.000386	CcSEcCtD
Ganciclovir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.54e-05	0.000386	CcSEcCtD
Ganciclovir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.54e-05	0.000386	CcSEcCtD
Ganciclovir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000385	CcSEcCtD
Ganciclovir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.53e-05	0.000385	CcSEcCtD
Ganciclovir—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.53e-05	0.000385	CcSEcCtD
Ganciclovir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.51e-05	0.000383	CcSEcCtD
Ganciclovir—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.51e-05	0.000383	CcSEcCtD
Ganciclovir—Pain—Efavirenz—acquired immunodeficiency syndrome	3.51e-05	0.000383	CcSEcCtD
Ganciclovir—Rash—Nevirapine—acquired immunodeficiency syndrome	3.51e-05	0.000383	CcSEcCtD
Ganciclovir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.51e-05	0.000383	CcSEcCtD
Ganciclovir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.5e-05	0.000382	CcSEcCtD
Ganciclovir—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.5e-05	0.000382	CcSEcCtD
Ganciclovir—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.5e-05	0.000381	CcSEcCtD
Ganciclovir—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.49e-05	0.000381	CcSEcCtD
Ganciclovir—Headache—Nevirapine—acquired immunodeficiency syndrome	3.49e-05	0.00038	CcSEcCtD
Ganciclovir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.00038	CcSEcCtD
Ganciclovir—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.00038	CcSEcCtD
Ganciclovir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.00038	CcSEcCtD
Ganciclovir—Infection—Saquinavir—acquired immunodeficiency syndrome	3.47e-05	0.000379	CcSEcCtD
Ganciclovir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.47e-05	0.000378	CcSEcCtD
Ganciclovir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.46e-05	0.000378	CcSEcCtD
Ganciclovir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.46e-05	0.000377	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.46e-05	0.000377	CcSEcCtD
Ganciclovir—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.45e-05	0.000377	CcSEcCtD
Ganciclovir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000375	CcSEcCtD
Ganciclovir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.44e-05	0.000375	CcSEcCtD
Ganciclovir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.44e-05	0.000375	CcSEcCtD
Ganciclovir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.43e-05	0.000374	CcSEcCtD
Ganciclovir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.42e-05	0.000373	CcSEcCtD
Ganciclovir—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.42e-05	0.000373	CcSEcCtD
Ganciclovir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.42e-05	0.000372	CcSEcCtD
Ganciclovir—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.4e-05	0.000371	CcSEcCtD
Ganciclovir—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.4e-05	0.000371	CcSEcCtD
Ganciclovir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.4e-05	0.000371	CcSEcCtD
Ganciclovir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.4e-05	0.00037	CcSEcCtD
Ganciclovir—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3.4e-05	0.00037	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.39e-05	0.00037	CcSEcCtD
Ganciclovir—Rash—Stavudine—acquired immunodeficiency syndrome	3.39e-05	0.00037	CcSEcCtD
Ganciclovir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.39e-05	0.000369	CcSEcCtD
Ganciclovir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.39e-05	0.000369	CcSEcCtD
Ganciclovir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.38e-05	0.000369	CcSEcCtD
Ganciclovir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000369	CcSEcCtD
Ganciclovir—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.38e-05	0.000368	CcSEcCtD
Ganciclovir—Headache—Stavudine—acquired immunodeficiency syndrome	3.37e-05	0.000367	CcSEcCtD
Ganciclovir—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.37e-05	0.000367	CcSEcCtD
Ganciclovir—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.000367	CcSEcCtD
Ganciclovir—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.36e-05	0.000366	CcSEcCtD
Ganciclovir—Pain—Delavirdine—acquired immunodeficiency syndrome	3.36e-05	0.000366	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.36e-05	0.000366	CcSEcCtD
Ganciclovir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.35e-05	0.000366	CcSEcCtD
Ganciclovir—Rash—Abacavir—acquired immunodeficiency syndrome	3.34e-05	0.000364	CcSEcCtD
Ganciclovir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.34e-05	0.000364	CcSEcCtD
Ganciclovir—Oedema—Lamivudine—acquired immunodeficiency syndrome	3.34e-05	0.000364	CcSEcCtD
Ganciclovir—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.34e-05	0.000364	CcSEcCtD
Ganciclovir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.33e-05	0.000364	CcSEcCtD
Ganciclovir—Headache—Abacavir—acquired immunodeficiency syndrome	3.32e-05	0.000362	CcSEcCtD
Ganciclovir—Infection—Lamivudine—acquired immunodeficiency syndrome	3.31e-05	0.000361	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.31e-05	0.000361	CcSEcCtD
Ganciclovir—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.31e-05	0.000361	CcSEcCtD
Ganciclovir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.31e-05	0.000361	CcSEcCtD
Ganciclovir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.29e-05	0.000358	CcSEcCtD
Ganciclovir—Hypotension—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000356	CcSEcCtD
Ganciclovir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.27e-05	0.000356	CcSEcCtD
Ganciclovir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000356	CcSEcCtD
Ganciclovir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.26e-05	0.000356	CcSEcCtD
Ganciclovir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.25e-05	0.000354	CcSEcCtD
Ganciclovir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.25e-05	0.000354	CcSEcCtD
Ganciclovir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000353	CcSEcCtD
Ganciclovir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.24e-05	0.000353	CcSEcCtD
Ganciclovir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.24e-05	0.000353	CcSEcCtD
Ganciclovir—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.23e-05	0.000352	CcSEcCtD
Ganciclovir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.23e-05	0.000352	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.21e-05	0.00035	CcSEcCtD
Ganciclovir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.2e-05	0.000349	CcSEcCtD
Ganciclovir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.2e-05	0.000349	CcSEcCtD
Ganciclovir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.2e-05	0.000349	CcSEcCtD
Ganciclovir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.2e-05	0.000349	CcSEcCtD
Ganciclovir—Nausea—Stavudine—acquired immunodeficiency syndrome	3.19e-05	0.000348	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.19e-05	0.000347	CcSEcCtD
Ganciclovir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000347	CcSEcCtD
Ganciclovir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.16e-05	0.000345	CcSEcCtD
Ganciclovir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.16e-05	0.000344	CcSEcCtD
Ganciclovir—Nausea—Abacavir—acquired immunodeficiency syndrome	3.15e-05	0.000343	CcSEcCtD
Ganciclovir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.000342	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.14e-05	0.000342	CcSEcCtD
Ganciclovir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.13e-05	0.000342	CcSEcCtD
Ganciclovir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.12e-05	0.00034	CcSEcCtD
Ganciclovir—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.12e-05	0.00034	CcSEcCtD
Ganciclovir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.00034	CcSEcCtD
Ganciclovir—Hypotension—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.00034	CcSEcCtD
Ganciclovir—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.11e-05	0.000339	CcSEcCtD
Ganciclovir—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.11e-05	0.000339	CcSEcCtD
Ganciclovir—Pain—Ritonavir—acquired immunodeficiency syndrome	3.11e-05	0.000339	CcSEcCtD
Ganciclovir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.11e-05	0.000339	CcSEcCtD
Ganciclovir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.11e-05	0.000339	CcSEcCtD
Ganciclovir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.09e-05	0.000337	CcSEcCtD
Ganciclovir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.08e-05	0.000336	CcSEcCtD
Ganciclovir—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.08e-05	0.000335	CcSEcCtD
Ganciclovir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.04e-05	0.000332	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.04e-05	0.000331	CcSEcCtD
Ganciclovir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3.03e-05	0.00033	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.02e-05	0.000329	CcSEcCtD
Ganciclovir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.02e-05	0.000329	CcSEcCtD
Ganciclovir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.02e-05	0.000329	CcSEcCtD
Ganciclovir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000327	CcSEcCtD
Ganciclovir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.99e-05	0.000327	CcSEcCtD
Ganciclovir—Pain—Saquinavir—acquired immunodeficiency syndrome	2.99e-05	0.000326	CcSEcCtD
Ganciclovir—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.99e-05	0.000326	CcSEcCtD
Ganciclovir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000324	CcSEcCtD
Ganciclovir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.97e-05	0.000324	CcSEcCtD
Ganciclovir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.97e-05	0.000324	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.97e-05	0.000324	CcSEcCtD
Ganciclovir—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000323	CcSEcCtD
Ganciclovir—Rash—Zidovudine—acquired immunodeficiency syndrome	2.95e-05	0.000321	CcSEcCtD
Ganciclovir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.95e-05	0.000321	CcSEcCtD
Ganciclovir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.94e-05	0.000321	CcSEcCtD
Ganciclovir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.94e-05	0.00032	CcSEcCtD
Ganciclovir—Headache—Zidovudine—acquired immunodeficiency syndrome	2.93e-05	0.000319	CcSEcCtD
Ganciclovir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.91e-05	0.000317	CcSEcCtD
Ganciclovir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.9e-05	0.000316	CcSEcCtD
Ganciclovir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.89e-05	0.000316	CcSEcCtD
Ganciclovir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.000315	CcSEcCtD
Ganciclovir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.88e-05	0.000314	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.88e-05	0.000314	CcSEcCtD
Ganciclovir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.88e-05	0.000314	CcSEcCtD
Ganciclovir—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.87e-05	0.000313	CcSEcCtD
Ganciclovir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000313	CcSEcCtD
Ganciclovir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000313	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.86e-05	0.000312	CcSEcCtD
Ganciclovir—Pain—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000311	CcSEcCtD
Ganciclovir—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000311	CcSEcCtD
Ganciclovir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.82e-05	0.000307	CcSEcCtD
Ganciclovir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.81e-05	0.000306	CcSEcCtD
Ganciclovir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.78e-05	0.000303	CcSEcCtD
Ganciclovir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000303	CcSEcCtD
Ganciclovir—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.78e-05	0.000303	CcSEcCtD
Ganciclovir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000301	CcSEcCtD
Ganciclovir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000301	CcSEcCtD
Ganciclovir—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.76e-05	0.000301	CcSEcCtD
Ganciclovir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.75e-05	0.0003	CcSEcCtD
Ganciclovir—Rash—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000299	CcSEcCtD
Ganciclovir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000299	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.73e-05	0.000298	CcSEcCtD
Ganciclovir—Headache—Indinavir—acquired immunodeficiency syndrome	2.72e-05	0.000297	CcSEcCtD
Ganciclovir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.72e-05	0.000296	CcSEcCtD
Ganciclovir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.69e-05	0.000293	CcSEcCtD
Ganciclovir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.68e-05	0.000292	CcSEcCtD
Ganciclovir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000289	CcSEcCtD
Ganciclovir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.64e-05	0.000288	CcSEcCtD
Ganciclovir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.64e-05	0.000288	CcSEcCtD
Ganciclovir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.61e-05	0.000285	CcSEcCtD
Ganciclovir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.61e-05	0.000284	CcSEcCtD
Ganciclovir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.6e-05	0.000283	CcSEcCtD
Ganciclovir—Rash—Efavirenz—acquired immunodeficiency syndrome	2.59e-05	0.000282	CcSEcCtD
Ganciclovir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.59e-05	0.000282	CcSEcCtD
Ganciclovir—Nausea—Indinavir—acquired immunodeficiency syndrome	2.58e-05	0.000282	CcSEcCtD
Ganciclovir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.58e-05	0.000281	CcSEcCtD
Ganciclovir—Headache—Efavirenz—acquired immunodeficiency syndrome	2.57e-05	0.000281	CcSEcCtD
Ganciclovir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.57e-05	0.00028	CcSEcCtD
Ganciclovir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000274	CcSEcCtD
Ganciclovir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.5e-05	0.000272	CcSEcCtD
Ganciclovir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.49e-05	0.000271	CcSEcCtD
Ganciclovir—Rash—Delavirdine—acquired immunodeficiency syndrome	2.48e-05	0.00027	CcSEcCtD
Ganciclovir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.48e-05	0.00027	CcSEcCtD
Ganciclovir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.47e-05	0.00027	CcSEcCtD
Ganciclovir—Headache—Delavirdine—acquired immunodeficiency syndrome	2.46e-05	0.000268	CcSEcCtD
Ganciclovir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.46e-05	0.000268	CcSEcCtD
Ganciclovir—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.44e-05	0.000266	CcSEcCtD
Ganciclovir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.4e-05	0.000262	CcSEcCtD
Ganciclovir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.39e-05	0.000261	CcSEcCtD
Ganciclovir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.39e-05	0.000261	CcSEcCtD
Ganciclovir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.36e-05	0.000257	CcSEcCtD
Ganciclovir—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.33e-05	0.000255	CcSEcCtD
Ganciclovir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.31e-05	0.000252	CcSEcCtD
Ganciclovir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.31e-05	0.000252	CcSEcCtD
Ganciclovir—Rash—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.00025	CcSEcCtD
Ganciclovir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.00025	CcSEcCtD
Ganciclovir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.28e-05	0.000249	CcSEcCtD
Ganciclovir—Headache—Ritonavir—acquired immunodeficiency syndrome	2.28e-05	0.000248	CcSEcCtD
Ganciclovir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.22e-05	0.000242	CcSEcCtD
Ganciclovir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.21e-05	0.000241	CcSEcCtD
Ganciclovir—Rash—Saquinavir—acquired immunodeficiency syndrome	2.21e-05	0.00024	CcSEcCtD
Ganciclovir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.00024	CcSEcCtD
Ganciclovir—Headache—Saquinavir—acquired immunodeficiency syndrome	2.19e-05	0.000239	CcSEcCtD
Ganciclovir—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.16e-05	0.000235	CcSEcCtD
Ganciclovir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.12e-05	0.000231	CcSEcCtD
Ganciclovir—Rash—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000229	CcSEcCtD
Ganciclovir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000229	CcSEcCtD
Ganciclovir—Headache—Lamivudine—acquired immunodeficiency syndrome	2.09e-05	0.000228	CcSEcCtD
Ganciclovir—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.08e-05	0.000227	CcSEcCtD
Ganciclovir—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.98e-05	0.000216	CcSEcCtD
